News

Gene therapy developed at PTBTG in partnership with Institut Charcot

Published:10.09.26 — AVR-001 arises from research at the EPFL Bertarelli Platform for gene therapy (PTBTG) and is jointly developed by ReMedys Foundation and Avrion Therapeutics. The gene therapy program will now enter Institut Charcot’s integrated translational pipeline, with the aim of advancing it toward clinical evaluation.

Screening spheroids: a simpler model for complex diseases

Published:01.07.26 — The Biomolecular Screening Facility (BSF/PTCB) contributed to a research article reporting a simplified, scalable, and cost‑effective 3D spheroid model specifically designed for high‑throughput drug screening in cancer research.

COMET's 2‑Year Milestone at EPFL

Published:19.06.26 — It has been 2 years now since we began our journey with the Comet technology from Bio-Techne Spatial (Lunaphore), and we are pleased to celebrate this milestone with you.

EPFL and UNIL Drop Overheads for Access to Technology Platforms

Published:15.06.26 — EPFL and UNIL have removed the overheads associated with the use of technology platforms hosted by the partner institution. This agreement facilitates access to state-of-the-art equipment and specialized expertise while fostering synergy.

PTPSP expertise powers structure‑based drug innovation

Published:05.06.26 — The Protein Production and Structure Core Facility (PTPSP) empowers structure-guided drug discovery with expert know-how, advanced instrumentation and access to X-ray synchrotron beamtime.

From Data to Impact: Tools for Better Scientific Communication

Published:01.06.26 — The PTBIOP and SV Communications team invite you to a seminar and an afternoon of hands-on sessions on best practices and tools for communicating your data.